XTRA:FMEHealthcare
Fresenius Medical Care (XTRA:FME): Assessing Valuation Following Upbeat 2025 Outlook and Improved Earnings
Fresenius Medical Care (XTRA:FME) caught investors’ attention after releasing its outlook for 2025. The company’s guidance points to continuing revenue growth and a strong jump in operating income. Fresenius Medical Care also reported improved third-quarter and year-to-date earnings.
See our latest analysis for Fresenius Medical Care.
Fresenius Medical Care’s positive 2025 forecast and recent quarterly beat have helped the shares find firmer footing, even after a bumpy stretch this autumn...